X @Bloomberg
Bloomberg·2025-09-18 09:56
Novo rose the most in a month after its diabetes blockbuster Ozempic beat Lilly’s older drug Trulicity in a real-world survey of certain US patients https://t.co/N8B9C20Olx ...
Novo rose the most in a month after its diabetes blockbuster Ozempic beat Lilly’s older drug Trulicity in a real-world survey of certain US patients https://t.co/N8B9C20Olx ...